Scientists discover new genetic variants linked to malaria drug resistance in Africa.

Researchers at Brown University have identified genetic mutations in malaria parasites that reduce their susceptibility to current treatments, including artemether-lumefantrine, widely used in sub-Saharan Africa. Published in Nature Medicine, this discovery provides a molecular marker for tracking the spread of drug resistance, which is critical given CDC recommendations for longer therapy courses due to treatment failures. This finding is vital for global public health efforts to combat evolving malaria threats.